Search clinical trials for: Prospective and retrospective expectancy

Total 10383 results

Peking University Cancer Hospital & Institute

Not yet recruiting

Lenvatinib and Pembrolizumab in Resectable Mucosal Melanoma

Mucosal Melanoma | Neoadjuvant Treatment

China
Rigshospitalet, Denmark
Odense University Hospital; Zealand University Hospital; Aarhus University Hospital and other collaborators

Recruiting

Prospective Surveillance for Breast Cancer-Related Lymphedema (PROTECT)

Breast Cancer

Denmark
Zhejiang Provincial Center for Disease Control...
Liaoning Chengda Biotechnology CO., LTD

Active, not recruiting

Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province

Japanese Encephalitis | Vaccine Reaction | Vaccine Preventable Disease

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia

Oral Cavity Carcinoma | Oral Intraepithelial Neoplasia

United States
University of Maryland, Baltimore
United States Department of Defense

Recruiting

Consortium for Optimized Integration of Bio-Artificial Blood Components for Adaptive Resuscitation Therapy (CONCERT)

Hemorrhage | Hemodynamic Instability

United States
MedImmune LLC

Completed

Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer

Esophagitis | Non-Small Cell Lung Carcinoma | Pneumonitis

United States
ArQule, Inc. (a wholly owned subsidiary of Merck...

Terminated

Vevorisertib (ARQ 751) as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations (MK-4440-001)

Cancer | Solid Tumors

United States
Sun Pharmaceutical Industries Limited

Withdrawn

Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine

Stomatitis | Oral Mucositis
Dana-Farber Cancer Institute

Unknown

Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia

Fanconi's Anemia

United States
Sarawak General Hospital
University Malaysia Sarawak

Completed

Antibiotic Prophylaxis in Ragged Placental Membranes

Endometritis | Endometritis Postpartum | Membranes; Retained
University Health Network, Toronto

Completed

Lung and Diaphragm-Protective Ventilation by Means of Assessing Respiratory Work (LANDMARK)

Respiratory Insufficiency | Lung Injury | Mechanical Ventilation Complication | Diaphragm Injury

Canada
Crowd Health Research, LTD

Unknown

Corneal Cross-Linking Comparing Variables

Unstable Corneas

United States
Maastricht University Medical Center

Completed

A New Approach in Chronic Pain; Acceptance & Commitment Therapy-Exposure & Perspective Taking (ACT-EPT) (ACT-EPT)

Chronic Pain

Netherlands
Charite University, Berlin, Germany
Takeda

Unknown

Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis (MatchedQoL)

Short Bowel Syndrome | Intestinal Failure

Germany
Nycomed
NPS Pharma

Completed

Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Renal Impairment

Germany
Groupe Oncologie Radiotherapie Tete et Cou
Schering-Plough

Completed

Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas

Head and Neck Cancer

France
Yale University

Completed

A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence

Opioid Dependence

United States
Giulio DiDiodato

Completed

Improving Antibiotic Use in Hospitalized Patients With Pneumonia (CAPASP)

Pneumonia

Canada
University of Freiburg

Completed

Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients

Graft Versus Host Disease

Germany
Medical University of Vienna

Completed

Bridging Intestinal Failure With Teduglutide - a Case Report

Short Bowel Syndrome

Austria
Medical University of Vienna

Completed

Teduglutide in Short Bowel Syndrome Patients

Short Bowel Syndrome
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; MedImmune...

Completed

Amifostine for Head and Neck Irradiation in Lymphoma

Lymphoma | Non-Hodgkin's Lymphoma | Hodgkin's Disease

United States
The Dale & Frances Hughes Cancer Center
MedImmune LLC

Completed

Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities

Head and Neck Cancer | Lung Cancer

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes

Myelodysplastic Syndromes | Myelodysplastic/Myeloproliferative Neoplasms

United States, Canada, Australia, Puerto Rico
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer

Unspecified Adult Solid Tumor, Protocol Specific | Gestational Trophoblastic Tumor | Neurotoxicity | Peripheral Neuropathy

United States
Incyte Corporation

Not yet recruiting

A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

Chronic Graft-versus-host-disease
Federico II University

Completed

MGuard Stent in ST-elevation Myocardial Infarction (GUARDIAN)

ST-elevation Myocardial Infarction | Thrombus | Stents

Italy
University Health Network, Toronto
Kensington Screening Clinic

Completed

Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids (GLP-2 Biopsy)

Hyperlipidemias

Canada
Shire

Completed

Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral Support

Short Bowel Syndrome

Japan
Henry Ford Health System
L'Oreal

Active, not recruiting

Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects

Sun Damaged Skin

United States
Shire

Completed

A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome

Short Bowel Syndrome

United States, United Kingdom
Shire

Completed

Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared to Healthy Participants

Hepatic Impairment

United States
Assistance Publique - Hôpitaux de Paris
Imagine Institute

Completed

Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients (REVE)

Short Bowel Syndrome

France
University Health Network, Toronto

Completed

Plasma Lipoprotein Response to Glucagon-like Peptide-2 (GLP-2 Plasma)

Hyperlipidemias

Canada
Children's Hospital Medical Center, Cincinnati

Terminated

High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors

Solid Tumors | Brain Tumors

United States
Shire

Completed

Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study

Short Bowel Syndrome

United States, United Kingdom
Rush North Shore Medical Center

Completed

Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy

Unspecified Adult Solid Tumor, Protocol Specific | Drug/Agent Toxicity by Tissue/Organ

United States
Ashwin Somasundaram
EMD Serono; University of North Carolina, Chapel Hill

Completed

Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas

Gastric Adenocarcinoma | Metastasis | Esophageal Adenocarcinoma | HER-2 Gene Amplification

United States
Northwestern University
Respiratory Technology Corporation

Completed

Positive Predictive Value of the Dx-pH Probe for Predicting PPI Response in LPR

Extraesophageal Reflux | Laryngopharyngeal Reflux (LPR) | Reflux Laryngitis | Posterior Laryngitis

United States
Royal Victoria Hospital, Canada

Completed

Impact of a Regional Antimicrobial Stewardship on the Length of Stay of Patients Admitted to Hospital With Pneumonia (RASPCAP)

Pneumonia

Canada
Stanford University

Terminated

A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia

Trigeminal Neuralgia

United States
Washington University School of Medicine

Completed

Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer

Head and Neck Cancer
Mt. Sinai Medical Center, Miami
MedImmune LLC

Completed

Subcutaneous Amifostine Safety Study

Lymphoma | Head and Neck Cancer | Lung Cancer

United States
Fenmei Shi

Unknown

Influence of Moderate Inspired Oxygen Fraction (FiO2) and Protective Ventilation on Postoperative Pulmonary Complication

Hepatectomy

China
University of Miami
H. Lundbeck A/S

Terminated

Timing of PDA Closure and Respiratory Outcome in Premature Infants

Patent Ductus Arteriosus

United States
University of Iowa

Completed

Determination of Amifostine Levels During Radiation Therapy

Cancer

United States
Shannon Puhalla

Active, not recruiting

Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib

Metastatic Breast Cancer

United States
Takeda

Completed

A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older

Short Bowel Syndrome

Japan
Boston Children's Hospital
Takeda

Completed

Pediatric Teduglutide Registry (PTR)

Short Bowel Syndrome

United States
IRCCS Policlinico S. Matteo
Merck Sharp & Dohme LLC; Menarini Group

Unknown

Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients (MaNeLo)

Marfan Syndrome

Italy

Search clinical trials for: Prospective and retrospective expectancy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations